EMA alerts EU patients and healthcare professionals to reports of falsified Ozempic pens

View source ↗

Summary

EMA warns about reports of falsified Ozempic pens and provides guidance to patients and healthcare professionals to verify authenticity and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• OZEMPIC (semaglutide)